Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03502018 · ClinicalTrials.gov registry record · Phase 4
Hip Fracture Exparel Administration Trial Capsule During Hemiarthroplasty
A Phase 4 study of Femoral Neck Fractures and Intracapsular Fracture of Femur, sponsored by Maimonides Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT03502018: Completed Phase 4 study of Femoral Neck Fractures and Intracapsular Fracture of Femur, sponsored by Maimonides Medical Center.
NCT03502018 is a Phase 4 study of Femoral Neck Fractures and Intracapsular Fracture of Femur that has completed, run by Maimonides Medical Center. The registered enrollment target is 50 participants, below the 403-participant average among 8 other Femoral Neck Fractures trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03502018, a Phase 4 study of Femoral Neck Fractures and Intracapsular Fracture of Femur, has completed, sponsored by Maimonides Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the efficacy of Liposomal Bupivacaine (Exparel) in hip fracture patients undergoing hip hemiarthroplasty for femoral neck fractures through a posterior approach. Post-operative measures will be assessing pain, overall opiate use, delirium, time-to-ambulation and discharge status.
Primary Outcome
Primary outcome measure will be postoperative visual analogue scale (VAS from 0-10) pain scores. 0 = no pain, 10 = most pain
Conditions Studied
Interventions
- DRUG Saline
- DRUG Bupivacaine liposome
Study Locations (1)
New York
- Maimonides Medical Center - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2023-08-31 |
| Phase | Phase 4 |
What the finished NCT03502018 record still lists
NCT03502018 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 403-participant average among 8 other Femoral Neck Fractures trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Femoral Neck Fractures appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT03502018 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03502018 about?
NCT03502018 is a clinical study titled "Hip Fracture Exparel Administration Trial Capsule During Hemiarthroplasty". This study will examine the efficacy of Liposomal Bupivacaine (Exparel) in hip fracture patients undergoing hip hemiarthroplasty for femoral neck fractures through a posterior approach. Post-operative measures will be assessing pain, overall opiate use, delirium, time-to-ambulation and discharge sta...
What is the current status of trial NCT03502018?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2018-03-01. Estimated completion is 2023-08-31.
What conditions does trial NCT03502018 study?
This clinical trial studies the following conditions: Femoral Neck Fractures, Intracapsular Fracture of Femur, Hip Hemiarthroplasty.
What interventions are being tested in trial NCT03502018?
The interventions under investigation include: Saline (DRUG), Bupivacaine liposome (DRUG).
Who is sponsoring clinical trial NCT03502018?
This trial is sponsored by Maimonides Medical Center, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03502018 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Femoral Neck Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03502018's enrollment target sits among peer trials
50 5th of 8 higher than 2 of 8 other Femoral Neck Fractures trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Femoral Neck Fractures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
RECRUITING · NA
-
Opioid-Free Pain Treatment in Trauma Patients
RECRUITING · NA
-
MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP)
RECRUITING · NA
-
PENG vs FICB for Hip Fracture in ED Patients
RECRUITING · NA
-
FNS (FEMORAL NECK SYSTEM) Study
ACTIVE NOT RECRUITING
-
Insignia™ Hip Stem Outcomes Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI